Description
PNC-27 10MG supplied by PureTy Peptides for qualified laboratory buyers. Modality: Injectable; presentation: 10MG.
Areas of research interest
- Targeted cancer cell killing
- Potential selectivity for tumor cells
- Activity independent of normal p53 function
- Possible mitochondrial effects
Specifications
- Modality: Injectable
- Presentation: 10MG
- Purity target: ≥99% (batch-specific COA available on request)
For research use only. Not for human or animal use.
Reviews
There are no reviews yet.